Danielle Antalffy

Stock Analyst at UBS

(3.48)
# 926
Out of 5,150 analysts
202
Total ratings
46.55%
Success rate
5.63%
Average return

Stocks Rated by Danielle Antalffy

RxSight
Feb 26, 2026
Maintains: Neutral
Price Target: $8$9
Current: $7.93
Upside: +13.49%
Stryker
Feb 24, 2026
Maintains: Neutral
Price Target: $386$400
Current: $381.89
Upside: +4.74%
Tandem Diabetes Care
Feb 20, 2026
Maintains: Neutral
Price Target: $17$22
Current: $23.41
Upside: -6.02%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $60$55
Current: $30.99
Upside: +77.48%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $140$120
Current: $72.21
Upside: +66.18%
Zimmer Biomet Holdings
Jan 28, 2026
Maintains: Sell
Price Target: $88$86
Current: $95.75
Upside: -10.18%
Edwards Lifesciences
Jan 12, 2026
Maintains: Neutral
Price Target: $92$95
Current: $85.22
Upside: +11.48%
Sight Sciences
Dec 23, 2025
Maintains: Buy
Price Target: $7$12
Current: $5.41
Upside: +121.81%
Inspire Medical Systems
Dec 23, 2025
Maintains: Neutral
Price Target: $89$91
Current: $64.32
Upside: +41.48%
Glaukos
Dec 23, 2025
Maintains: Buy
Price Target: $140$145
Current: $115.37
Upside: +25.68%
Initiates: Buy
Price Target: $62
Current: $26.56
Upside: +133.43%
Maintains: Neutral
Price Target: $95$102
Current: $95.60
Upside: +6.69%
Upgrades: Buy
Price Target: $355$400
Current: $242.89
Upside: +64.68%
Maintains: Neutral
Price Target: $6.5$5.85
Current: $1.47
Upside: +297.96%
Maintains: Neutral
Price Target: $16$16
Current: $13.56
Upside: +17.99%
Maintains: Buy
Price Target: $106$95
Current: $72.90
Upside: +30.32%
Maintains: Neutral
Price Target: $24$21
Current: $19.03
Upside: +10.35%
Maintains: Neutral
Price Target: $585$600
Current: $501.18
Upside: +19.72%
Maintains: Buy
Price Target: $190$214
Current: $245.30
Upside: -12.76%
Maintains: Buy
Price Target: $65$57
Current: $25.79
Upside: +121.02%
Maintains: Buy
Price Target: $146$148
Current: $113.10
Upside: +30.86%
Initiates: Neutral
Price Target: $2.25
Current: $4.03
Upside: -44.17%
Maintains: Outperform
Price Target: $975$825
Current: $3.53
Upside: +23,271.10%
Maintains: Outperform
Price Target: $12$14
Current: $29.22
Upside: -52.09%
Maintains: Outperform
Price Target: $75$100
Current: $77.84
Upside: +28.47%
Maintains: Outperform
Price Target: $15$12
Current: $13.95
Upside: -13.98%
Maintains: Outperform
Price Target: $40$45
Current: $34.96
Upside: +28.72%
Maintains: Market Perform
Price Target: $270$275
Current: $171.49
Upside: +60.36%
Maintains: Outperform
Price Target: $26$20
Current: $2.87
Upside: +596.86%
Maintains: Market Perform
Price Target: $72$42
Current: $6.31
Upside: +565.61%
Downgrades: Market Perform
Price Target: $60
Current: $6.87
Upside: +773.36%
Initiates: Outperform
Price Target: $15
Current: $0.79
Upside: +1,798.73%